Clinical trial

Tocilizumab REMission in Early RA

NCT04157010

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhasePHASE4

Study timeline

Study start (unknown)2013-05-01Date precision: month

Registry last updated2019-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

TocilizumabDRUG

MethotrexateDRUG

Sponsors & collaborators

University of Leedslead sponsor

Hoffmann-La Rochecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04157010 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.